In breast cancer, BRD4 reorganises chromatin and facilitates recruitment of the LSD1–NuRD complex to SEs, which in turn with BRD4 occupies SEs, thereby repressing genes, and is functionally linked to drug resistance. Here, BRD4 is linked to breast cancer.